3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Sarcoma, Ewing's: new trials by email Literature Review of Sarcoma, Ewing's trials Research Report on Sarcoma, Ewing's
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors nab-paclitaxel - Neuroblastoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Completed | Celgene | 107 | 2013-12-04 | 2019-12-27 |
| A Study of Pemetrexed in Children With Recurrent Cancer pemetrexed - Osteosarcoma, Medulloblastoma | Phase 2 | Completed | Eli Lilly and Company | 72 | 2007-09-01 | 2011-02-25 |
| Trial of Dasatinib in Advanced Sarcomas Dasatinib - Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors | Phase 2 | Completed | Sarcoma Alliance for Research through Collaboration | 366 | 2007-05-01 | 2018-11-23 |
Rhabdomyosarcoma (3) · Sarcoma, Ewing (3) · Neuroblastoma (2) · Osteosarcoma (2) · Sarcoma (2) · Chondrosarcoma (1) · Chordoma (1) · Dermatofibrosarcoma (1) · Ependymoma (1) · Fibrosarcoma (1) · Gastrointestinal Stromal Tumors (1) · Giant Cell Tumor of Bone (1) · Hemangiopericytoma (1) · Histiocytoma (1) · Medulloblastoma (1)
Myosarcoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Bone Tissue (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Muscle Tissue (3) · Neoplasms, Nerve Tissue (3) · Neoplasms (2) · Neoplasms, Fibrous Tissue (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2) · Neuroectodermal Tumors, Primitive (2) · Neuroectodermal Tumors, Primitive, Peripheral (2)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Dasatinib (1) · Pemetrexed (1)
Celgene (1) · Eli Lilly and Company (1) · Sarcoma Alliance for Research through Collaboration (1)
United States (3) · Canada (1) · France (1) · Italy (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Ileana Elias, M.D. (1) · Scott Schuetze, MD, PhD (1)